Gilder Gagnon Howe & Co’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-105,515	Closed	-$2.54M	–	253
2023 Q3	$2.54M	Sell	105,515 -2,197	-2%	-$58.9K	0.04%	169
2023 Q2	$3.44M	Sell	107,712 -99	-0.1%	-$3.21K	0.05%	168
2023 Q1	$3.3M	Sell	107,811 -305	-0.3%	-$12K	0.05%	154
2022 Q4	$4.23M	Sell	108,116 -11,105	-9%	-$497K	0.08%	145
2022 Q3	$5.68M	Sell	119,221 -12,556	-10%	-$716K	0.1%	126
2022 Q2	$5.1M	Sell	131,777 -25,832	-16%	-$1.03M	0.09%	131
2022 Q1	$9.03M	Buy	157,609 +1,478	+0.9%	+$96.9K	0.08%	147
2021 Q4	$12.4M	Buy	156,131 +4,585	+3%	+$393K	0.07%	164
2021 Q3	$13.2M	Buy	151,546 +7,327	+5%	+$736K	0.07%	181
2021 Q2	$18.6M	Buy	144,219 +319	+0.2%	+$25.4K	0.09%	166
2021 Q1	$11.5M	Buy	143,900 +14,189	+11%	+$1.35M	0.06%	190
2020 Q4	$10.6M	Buy	129,711 +23,448	+22%	+$1.15M	0.05%	183
2020 Q3	$2.62M	Buy	106,263 +15,158	+17%	+$376K	0.02%	225
2020 Q2	$2.55M	Buy	91,105 +1,292	+1%	+$27.8K	0.02%	209
2020 Q1	$1.62M	Buy	+89,813	New	+$1.95M	0.02%	183